Table 4.
Population characteristics by mortality after liver transplant
| Alive at last follow-up N = 907 |
Dead at last follow-up N = 167 |
p-value | |
|---|---|---|---|
| Male, n (%) | 683 (75.3) | 125 (74.9) | 0.90 |
| Age (yr), mean (SD) | 56.6 (7.6) | 58.1 (7.1) | 0.02 |
| Race, n (%) | |||
| White | 417 (46.0) | 86 (51.5) | 0.55 |
| Black | 40 (4.4) | 10 (6.0) | |
| Asian/Pacific Islander | 217 (23.9) | 29 (17.4) | |
| Hispanic | 155 (17.1) | 27 (16.2) | |
| Other | 78 (8.6) | 15 (9.0) | |
| Underlying liver disease, number (%) | |||
| Hepatitis C | 504 (55.6) | 103 (61.7) | 0.35 |
| Hepatitis B | 104 (11.5) | 12 (7.2) | |
| Alcoholic liver disease | 69 (7.6) | 13 (7.8) | |
| HCC alone | 104 (11.5) | 19 (11.4) | |
| Other | 126 (13.9) | 20 (12.0) | |
| MELD score, mean (SD) | 13.8 (7.5) | 15.7 (14.3) | 0.004 |
| History of loco-regional therapy, number (%) | 600 (66.2) | 106 (63.5) | 0.50 |
| Waitlist time (days), median (IQR) | 209 (118–415) | 248 (118–620) | 0.05 |
| Donor Risk Index, mean (SD) | 1.41 (0.36) | 1.48 (0.38) | 0.01 |
| Initial AFP (ng/dL), median (IQR) | 11 (5–41) | 17 (7–90) | 0.005 |
| Final AFP (ng/dL), median (IQR) | 12 (5–49) | 23 (7–141) | 0.002 |
| HCC recurrence, number (%) | 13 (1.4) | 51 (30.5) | <0.001 |